TrialClinical & experimental metastasis2025

Reconsidering palliative radiotherapy in addition to PD-1 blockade for non-small cell lung cancer: results from the FORCE phase II trial (AIO/YMO-TRK-0415).

Farastuk Bozorgmehr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.